BIO Industry

Korea's Next-Generation Growth Driver: Bio Industry

Korea’s bio industry has great potential. The average national life span, which currently stands at 78.2, is quickly increasing, transforming Korea into an aging society at a rapid rate. Consequently, the bio industry is emerging as Korea’s next-generation growth industry. A cluster of global biotechnology companies is operating in Gyeonggi Province, making our province the heart of Korea’s bio industry.

The Outlook for Korea's Bio Industry
Korea's bio industry has been growing at a rate of 18% each year and is receiving full support from the government as a future growth industry

Korea's Bio Industry Heart: Gyeonggi Province 
Gyeonggi Province, a highly attractive investment destination for bio-tech companies, accounts for 46.9% of Korea's entire bio industry (based on the number of companies operating in the region) while 60.7% of the country's bio industry workforce is employed in the province. Furthermore, the province accounts for 68.6% of the R&D budget set aside for the industry.

Bio Industry Companies Located in Gyeonggi Province 
 
Domestic Companies (Research Centers / Manufacturing Plants)
Dong A Pharmaceutical, Green Gross Corporation, Hanmi Pharmaceutical, Jeil Pharmaceutical, Yuhan Corporation, Estech Pharma, Bukwang Pharmaceutical, SK Chemicals, Daewoong Pharmaceutical, Choongwae Pharma, Dong Wha Pharm., Ildong Pharmaceutical, Kwang Dong Pharmaceutical, etc.

Foreign Companies(Research Center / Manufacturing Plants)
Kimberly Clark Innovation Center Asia, sanofi-aventis, Janssen, MSD, GlaxoSmithKline, Abbott, Merck Advanced Technologies, Otsuka Pharmaceuticals, etc.


the source - http://www.invest.go.kr/content_eng/index.jsp?code=102021303